Sun Life Financial Inc. has proposed a $213.5 million settlement for a class action lawsuit involving life insurance policies issued by MetLife during the late 20th century. This lawsuit dates back to 2010, initiated by MetLife policyholders who alleged breaches in the sale and administration of approximately 230,000 life insurance policies sold between 1985 and 1998.
The crux of the issue lies in whether these policyholders were overcharged for insurance costs and fees. The plaintiffs originally sought a staggering $2.5 billion from Sun Life due to these alleged misrepresentations. These claims highlight significant concerns regarding the management of legacy policies that Sun Life inherited when it acquired Clarica Life Insurance Co. in 2002.
That context matters because it explains why Sun Life is now stepping forward to propose this settlement. When Sun Life took over Clarica, it also assumed responsibility for these problematic MetLife policies, which include Universal Plus, Flexiplus, or Optimet plans sold between 1987 and 1998.
In response to this legal challenge, Sun Life has stated that it would pay up to $213.5 million to eligible policyholders. However, none of the allegations have been proven in court, and the settlement still requires court approval before it can be finalized.
Eligible policyholders can register their information online to claim part of the settlement, but uncertainties remain regarding how much each individual might receive. Class members have been categorized into three groups based on their specific policies.
Furthermore, MetLife provided Sun Life with an indemnity concerning these policies, indicating that they may share some responsibility in this matter. As this case unfolds, it will be crucial to monitor how the courts respond to this proposed settlement and what implications it holds for both companies involved.
Ultimately, while the proposed settlement offers some resolution for affected policyholders, many questions linger about the extent of compensation and potential future developments in similar cases involving legacy insurance products.
